Clinical TrialsSearch results
Number of results: 210
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- Exploration of sleep effects
- - Deep sleep percentage - Work Engagement - Self Efficacy - Cognitive function
- Nakao Mutsuhiro
- 2024-08-19
Other
- Impact of Life Design Support and Community Activities on Workers' Self-Usefulness
- Prevention of depression and other symptoms resulting from social isolation and loneliness
- Narimatu Hiroto
- 2024-06-14
Recruiting
- Examining the Effectiveness of Interventions on Lifestyle Functioning in Long-Term Care Prevention Projects
- frail elderly Improved physical and cognitive function, increased social interaction
- Hoshi Masayuki
- 2024-03-20
Recruiting
- Penicillin oral challenge test for patients with low-risk penicillin allergy.
- Penicillin allergy
- Shinozaki Toshiyuki
- 2024-03-12
Recruiting
- MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Multiple Myeloma
- Kawai Norisuke
- 2024-01-26
Recruiting
- [M23-477] Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
- Acute myeloid leukemia
- Okubo Sumiko
- 2023-11-25
Recruiting
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients With Eosinophilic Esophagitis (CROSSING).
- Eosinophilic Esophagitis
- Ageishi Yuji
- 2023-07-25
Recruiting
- Efficacy and Safety Trial of Epcoritamab With or Without Lenalidomide as First Line Therapy for Subjects With Diffuse Large B-cell Lymphoma
- People must be newly diagnosed with DLBCL and anthracycline-ineligible.
- Hoehn Daniela
- 2023-07-07
Other
- A Phase 3 study of Epcoritamab in Subjects With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Satomi Natsuko
- 2023-02-09
Recruiting
- A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Multiple Myeloma
- Kawai Norisuke
- 2022-12-26